https://www.bloomedi.com/ko/media/skin/dong-a-pharm-launches-five-deep-barrier-pro-moisturizers-a05185 MediIndex ko 2026-10-02T10:34:34.593Z 동아제약, 극건조 피부용 딥 베리어 프로 5종 출시 https://www.bloomedi.com/en/media/skin/dong-a-pharm-launches-five-deep-barrier-pro-moisturizers-a05185 MediIndex en 2026-10-02T10:34:34.593Z Dong-A Pharm Launches Five Deep Barrier Pro Moisturizers https://www.bloomedi.com/ko/media/skin/daewoong-hosts-nabota-academy-for-partners-from-22-countries-d3a978 MediIndex ko 2026-10-02T04:35:08.958Z 대웅제약, 22개국 파트너 대상 나보타 글로벌 아카데미 개최 https://www.bloomedi.com/en/media/skin/daewoong-hosts-nabota-academy-for-partners-from-22-countries-d3a978 MediIndex en 2026-10-02T04:35:08.958Z Daewoong Hosts Nabota Academy for Partners From 22 Countries https://www.bloomedi.com/ko/media/body/tiqure-and-kosin-hospital-begin-metabolic-endoscopy-study-426837 MediIndex ko 2026-10-02T02:39:36.871Z 티큐어·고신대학교복음병원, 비만·당뇨 내시경 의료기기 임상연구 착수 https://www.bloomedi.com/en/media/body/tiqure-and-kosin-hospital-begin-metabolic-endoscopy-study-426837 MediIndex en 2026-10-02T02:39:36.871Z TiQure and Kosin Hospital Begin Metabolic Endoscopy Study https://www.bloomedi.com/ko/media/eye/eylea-8-mg-study-finds-vision-and-retinal-gains-in-routine-care-41ce17 MediIndex ko 2026-10-02T02:37:19.900Z 아일리아 8mg 실제 진료 연구서 시력·망막 지표 개선 https://www.bloomedi.com/en/media/eye/eylea-8-mg-study-finds-vision-and-retinal-gains-in-routine-care-41ce17 MediIndex en 2026-10-02T02:37:19.900Z Eylea 8 mg Study Finds Vision and Retinal Gains in Routine Care https://www.bloomedi.com/ko/media/breast/breast-conserving-surgery-can-avoid-full-breast-removal-75307d MediIndex ko 2026-10-02T02:35:36.043Z 유방암 조기 발견 시 유방 전체 제거 대신 보존술 가능 https://www.bloomedi.com/en/media/breast/breast-conserving-surgery-can-avoid-full-breast-removal-75307d MediIndex en 2026-10-02T02:35:36.043Z Breast-Conserving Surgery Can Avoid Full Breast Removal https://www.bloomedi.com/ko/media/breast/korean-societies-define-limits-on-mammotome-use-for-breast-tumors-68d976 MediIndex ko 2026-10-02T00:35:58.370Z 유방 종양 맘모톰 적용 기준, 악성 의심·확진 병변은 제외 https://www.bloomedi.com/en/media/breast/korean-societies-define-limits-on-mammotome-use-for-breast-tumors-68d976 MediIndex en 2026-10-02T00:35:58.370Z Korean Societies Define Limits on Mammotome Use for Breast Tumors https://www.bloomedi.com/ko/media/skin/lameditech-and-saengki-partner-on-skin-laser-devices-43e6bb MediIndex ko 2026-10-01T04:25:59.135Z 라메디텍·생기한의원, 피부 레이저 치료기기 공동 연구 협약 https://www.bloomedi.com/en/media/skin/lameditech-and-saengki-partner-on-skin-laser-devices-43e6bb MediIndex en 2026-10-01T04:25:59.135Z Lameditech and Saengki Partner on Skin Laser Devices